FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28420911000001109: Vamju 60mg modified-release tablets (AMCo) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89310801000001111 Vamju 60mg modified-release tablets (AMCo) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111519301000001117 Vamju 60mg modified-release tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vamju 60mg modified-release tablets (AMCo) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Is a Gliclazide 60mg modified-release tablets true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has excipient Lactose false Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Is a Vamju true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Vamju 60mg modified-release tablets (AMCo) 28 tablet 2 x 14 tablets Has AMP True Vamju 60mg modified-release tablets (AMCo) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start